[{"data":1,"prerenderedAt":64},["ShallowReactive",2],{"q-nurse-112-3-medical-surgical-009":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":34,"lastmod":63},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":10},"nurse-112-3-內外科護理學-009","nurse-112-3-medical-surgical-009",112,3,9,"有關消化性潰瘍藥物治療之目的，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"中和胃酸","促進胃排空","減少胃酸分泌","保護黏膜屏障","B",null,[],"本題考點在於消化性潰瘍藥物治療的目標。本題為反向題，錯誤選項為 B：消化性潰瘍藥物治療的目的是降低胃酸對黏膜的侵蝕並促進癒合，包括中和胃酸、減少胃酸分泌與保護黏膜屏障，而「促進胃排空」並非潰瘍藥物的治療目的，故選 B。判斷關鍵是「治療潰瘍不以促進胃排空為目標」。A 制酸劑中和胃酸，B 誤。C 質子幫浦抑制劑與 H2 受體拮抗劑減少胃酸分泌，D 黏膜保護劑（如 sucralfate）形成保護層，皆為正確治療目的。","消化性潰瘍治療圍繞「降酸、護膜、除菌」三軸：降酸藥有制酸劑（中和已分泌胃酸）、H2 受體拮抗劑與 PPI（抑制胃酸分泌）；護膜藥如 sucralfate、bismuth 於潰瘍面形成屏障；若合併幽門螺旋桿菌感染則須抗生素三合一療法根除。促進胃排空的藥物（如 metoclopramide）用於胃輕癱或胃食道逆流，與潰瘍癒合目標不同，故為本題反向答案。",[24,26,29,31],{"term":25,"count":10},"質子幫浦抑制劑",{"term":27,"count":28},"制酸劑",2,{"term":30,"count":28},"黏膜保護劑",{"term":32,"count":33},"消化性潰瘍藥物",1,[35,39,44,48,53,58],{"webId":36,"stem":37,"number":38,"year":9,"session":10},"nurse-112-3-medical-surgical-010","常見肝硬化形成腹水的原因，下列何者正確？",10,{"webId":40,"stem":41,"number":42,"year":43,"session":28},"nurse-113-2-medical-surgical-006","腦中風病人有吞嚥困難的問題，由口進食的食物性狀須採漸進性改變，下列何者是最後採用的類型？",6,113,{"webId":45,"stem":46,"number":47,"year":43,"session":10},"nurse-113-3-medical-surgical-050","有關各類型休克其病理機轉是因血管擴張引起分布性（distributive）或稱血管性（vasogenic）休克，下列何者正確？①敗血性 ②低血容積性 ③過敏性 ④神經性 ⑤心因性",50,{"webId":49,"stem":50,"number":51,"year":52,"session":33},"nurse-115-1-medical-surgical-048","有關有機磷中毒臨床處置之敘述，下列何者錯誤？",48,115,{"webId":54,"stem":55,"number":56,"year":57,"session":28},"nurse-106-2-medical-surgical-072","為路倒者執行心肺腦復甦術期間，當接上電擊器顯示為心搏停止，此時應執行之急救措施，下列何者正確？",72,106,{"webId":59,"stem":60,"number":61,"year":62,"session":33},"nurse-108-1-medical-surgical-026","有關心臟衰竭臨床處置之敘述，下列何者錯誤？",26,108,"2026-09-04",1788510744840]